CAPZA2::MET Fusion and MET Amplification in EGFR-Mutated Advanced Non–Small Cell Lung Cancer With Marked Response to Capmatinib Monotherapy: A Case Report

JTO Clinical and Research Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles